能倍乐 思力华噻托溴铵从哪里买便宜

(also called Tiotropium bromide) is a long-acting anticholinergic drug suitable for the maintenance treatment of chronic obstructive pulmonary disease (COPD). In our country, the number of people who die from COPD every year is as high as 1.28 million, and people’s life safety is seriously threatened. Respimat is currently on the market in my country, and patients can choose to purchase it domestically.

In the experimental research center, Respimat, Slava, Tiotropium bromide has a high affinity with receptors in human airways, and dissociates slowly from muscarinic M1 and M3 receptors, which can block cholinergic nerve-mediated contraction of bronchial smooth muscle for a long time. However, Respimat dissociates from the muscarinic M2 receptor quite quickly, thus showing unique kinetic selectivity for M1 and M3 receptors.

In addition to domestic Respimat, we learned that the price of each box of Respimat abroad is around 170$, which is a relatively cheap price and can be afforded by most domestic families. The price may change due to various factors such as exchange rates. Patients can consult the Medical Partner Travel Overseas Medical Consulting Service Company for specific prices and purchase methods.

When using Respimat, Tiotropium and Slivar, insert it into the sprayer, press the device, and the solution will be sprayed out in the form of mist. For inhalation use only. The recommended dose for adults is 2 puffs taken once daily via the Respimat inhaler device, preferably at the same time each day. Do not overdose. Do not start treatment with Respimat if you are allergic to this product or its ingredients.

The simultaneous use of tiotropium and some drugs may cause drug interactions, causing the emergence or worsening of some side effects. If the patient needs to take other drugs at the same time, please inform the doctor in advance; patients with prostatic hyperplasia, narrow-angle glaucoma, or bladder neck obstruction should use it with caution and do not use the drug blindly.

Recommended related hot articles: /newsDetail/85078.html